Published in Oncotarget on September 30, 2014
Review of the development of DNA methylation as a marker of response to neoadjuvant therapy and outcomes in rectal cancer. Clin Epigenetics (2015) 0.81
Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma. Oncotarget (2016) 0.77
Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer. Int J Mol Sci (2016) 0.76
Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer. Int J Mol Sci (2017) 0.75
An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73
Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68
Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet (2012) 15.21
CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02
Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects. Nucleic Acids Res (2001) 12.92
CpG islands and the regulation of transcription. Genes Dev (2011) 9.50
A comparison of background correction methods for two-colour microarrays. Bioinformatics (2007) 8.59
Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci U S A (2005) 8.10
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol (2006) 7.05
Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol (2005) 6.00
Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol (2012) 5.41
Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet (2010) 4.20
NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw (2009) 3.37
Interplay between the cancer genome and epigenome. Cell (2013) 3.05
The diverse functions of Dot1 and H3K79 methylation. Genes Dev (2011) 2.66
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol (2010) 2.28
Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol (2012) 2.22
The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys (2005) 2.18
Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol (2012) 2.00
The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis. PLoS Biol (2010) 1.81
[Update S3-guideline "colorectal cancer" 2008]. Z Gastroenterol (2008) 1.81
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66
Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomas. Int J Cancer (2011) 1.65
CpG island hypermethylation in human astrocytomas. Cancer Res (2010) 1.57
Magnetic resonance imaging cannot predict histological tumour involvement of a circumferential surgical margin in rectal cancer. Colorectal Dis (2010) 1.44
The CpG island methylator phenotype in colorectal cancer: progress and problems. Biochim Biophys Acta (2011) 1.43
DNA methylation biomarkers for lung cancer. Tumour Biol (2011) 1.35
Methylation of DNA in cancer. Adv Clin Chem (2010) 1.31
Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. J Natl Cancer Inst (2012) 1.30
Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer (2009) 1.29
Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location. Br J Cancer (2013) 1.28
Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial. J Clin Oncol (2004) 1.24
A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR. Epigenetics (2012) 1.05
A Boolean-based systems biology approach to predict novel genes associated with cancer: Application to colorectal cancer. BMC Syst Biol (2011) 1.02
Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer. Br J Cancer (2013) 1.01
The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies. Langenbecks Arch Surg (2012) 0.99
Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. FASEB J (2012) 0.99
Dissecting DNA hypermethylation in cancer. FEBS Lett (2010) 0.98
DNA methylation changes in cells regrowing after fractioned ionizing radiation. Radiother Oncol (2011) 0.96
Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer. Clin Cancer Res (2010) 0.96
Induction chemotherapy with capecitabine and oxaliplatin followed by chemoradiotherapy before total mesorectal excision in patients with locally advanced rectal cancer. Ann Oncol (2012) 0.94
CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer. Surgery (2011) 0.93
Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer. J Clin Oncol (2011) 0.91
RNF220, an E3 ubiquitin ligase that targets Sin3B for ubiquitination. Biochem Biophys Res Commun (2010) 0.87
KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer. Int J Cancer (2013) 0.86
Prognostic significance of response to preoperative radiotherapy, lymph node metastasis, and CEA level in patients undergoing total mesorectal excision of rectal cancer. Int J Colorectal Dis (2010) 0.84
ERas enhances resistance to CPT-11 in gastric cancer. Anticancer Res (2011) 0.84
Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy? J Cell Physiol (2013) 0.83
ERas oncogene expression and epigenetic regulation by histone acetylation in human cancer cells. Anticancer Res (2008) 0.83
Enrichment of methylated DNA by methyl-CpG immunoprecipitation. Methods Mol Biol (2013) 0.83
Resistance to chemotherapeutic agents and promotion of transforming activity mediated by embryonic stem cell-expressed Ras (ERas) signal in neuroblastoma cells. Int J Oncol (2010) 0.81
ik3-2, a relative to ik3-1/Cables, is involved in both p53-mediated and p53-independent apoptotic pathways. Biochem Biophys Res Commun (2003) 0.78
Integrative epigenome analysis identifies a Polycomb-targeted differentiation program as a tumor-suppressor event epigenetically inactivated in colorectal cancer. Cell Death Dis (2014) 0.76
Towards a "Lyon molecular signature" to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signature. Cancer Radiother (2012) 0.76
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia. Nat Genet (2016) 1.06
BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence. Nat Genet (2014) 0.98
Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia. Int J Cancer (2015) 0.84
Retinoid resistance and multifaceted impairment of retinoic acid synthesis in glioblastoma. Glia (2015) 0.82
Environment-induced epigenetic reprogramming in genomic regulatory elements in smoking mothers and their children. Mol Syst Biol (2016) 0.82
Increased vitamin D levels at birth and in early infancy increase offspring allergy risk-evidence for involvement of epigenetic mechanisms. J Allergy Clin Immunol (2015) 0.77
Prognostic relevance of miRNA-155 methylation in anaplastic glioma. Oncotarget (2016) 0.75
Heterogeneity of KRAS Mutation Status in Rectal Cancer. PLoS One (2016) 0.75
BET-bromodomain inhibitors modulate epigenetic patterns at the diacylglycerol kinase alpha enhancer associated with radiation-induced fibrosis. Radiother Oncol (2017) 0.75
NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib. Int J Cancer (2017) 0.75
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases. Clin Sarcoma Res (2017) 0.75
Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues. Nat Immunol (2017) 0.75
Effectiveness of fourth-line dual immunotherapy in hepatocellular carcinoma with simultaneous steroid administration for immune-related hepatitis. Therap Adv Gastroenterol (2022) 0.75
Maternal Phthalate Exposure Promotes Allergic Airway Inflammation over Two Generations Via Epigenetic Modifications. J Allergy Clin Immunol (2017) 0.75